Eli Lilly and Applied Neurosolutions have an agreement which, while certain timelines are fulfilled, increases the income and research potential in finding a viable drug for Alzheimer's disease. Dr. Peter Davies is a well renowned, world renowned research analyst for Alzheimer's, he's under contract with Applied Neurosolution's for this very reason. Pfizer and Johnson & Johnson have given up research and development of a viable drug, for now.
Keep abreast of updates, successes and failures of trials for the drug Solanezumub and you'll begin to understand the potential capital gains your investment will provide.
Google Applied Neurosolutions every once in awhile as development of this drug and FDA approval will eventually come...
Be Well...